Search - tctmd.com

Displaying 641 - 660 of 1200

Sort: Relevancy | Date

Presentation THT 2024

When to consider AccuCinch

Presenter: Sean P. Pinney

March 04, 2024

Presentation THT 2024

Right Heart Function and Flow Dynamics with Different Left-to-Right Shunt Approaches

Presenter: Sanjiv J. Shah

March 04, 2024

Presentation THT 2024

Achieving Heart Recovery in HF with Cardiogenic Shock

Presenter: Debbie Rinde-Hoffman

March 04, 2024

Presentation THT 2024

Transcatether Left Ventricular Restoration (TLVR): The AccuCinch Approach

Presenter: Ulrich P. Jorde

March 04, 2024

Presentation THT 2024

Which Patients Will Benefit from Left-to-Right Shunting?

Presenter: Ryan J. Tedford

March 04, 2024

Presentation THT 2024

Why Treat The Dilated Left Ventricle

Presenter: Daniel Burkhoff

March 04, 2024

Presentation THT 2024

Left-to-Right Shunting for Chronic Heart Failure: Overview of the Device Landscape

Presenter: Benjamin Hibbert

March 04, 2024

Presentation THT 2024

Healing Hearts: Achieving Native Heart Recovery

Presenter: Scott Silvestry

March 04, 2024

Presentation THT 2024

Future HF Trials Should Focus on Patients in the High-Risk Period After an ADHF Hospitalization

Presenter: Gad Cotter

March 04, 2024

Presentation THT 2024

The Future of Heart Failure Trials: Faster, Better and More Efficient Approaches to Approvals

Presenter: Scott Solomon

March 04, 2024

Presentation THT 2024

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Presenter: Michael R. Zile

March 04, 2024

Presentation THT 2024

New Approaches to Treating Heart Failure

Presenter: W. H. Wilson Tang

March 04, 2024

Presentation THT 2024

Participant-Centric, Digital, and Decentralized: What Are the Innovations We Need in How We Do Research?

Presenter: Harlan Krumholz

March 04, 2024

Presentation THT 2024

Addressing the HF Physician Shortage “Crisis”

Presenter: Mark Drazner

March 04, 2024

Presentation THT 2024

How I Manage AMI-Shock in 2024

Presenter: Dirk Westermann

March 04, 2024

Presentation THT 2024

3000 Years in the Making: Traditional Chinese Herbal Medicines for Heart Failure

Presenter: Milton Packer

March 04, 2024

Presentation THT 2024

The OBESITY-HF Connection: Time to Attack This Head-on

Presenter: Barry Borlaug

March 04, 2024

Presentation THT 2024

How CRISPR Will Be Used to Prevent Heart Failure

Presenter: Christine Seidman

March 04, 2024

Presentation THT 2024

Utilization of Advanced Heart Failure Interventions Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Presenter: William T. Abraham

March 04, 2024

Presentation THT 2024

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Presenter: JoAnn Lindenfeld

March 04, 2024

Advertisement

When to consider AccuCinch

Right Heart Function and Flow Dynamics with Different Left-to-Right Shunt Approaches

Achieving Heart Recovery in HF with Cardiogenic Shock

Transcatether Left Ventricular Restoration (TLVR): The AccuCinch Approach

Which Patients Will Benefit from Left-to-Right Shunting?

Why Treat The Dilated Left Ventricle

Left-to-Right Shunting for Chronic Heart Failure: Overview of the Device Landscape

Healing Hearts: Achieving Native Heart Recovery

Future HF Trials Should Focus on Patients in the High-Risk Period After an ADHF Hospitalization

The Future of Heart Failure Trials: Faster, Better and More Efficient Approaches to Approvals

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

New Approaches to Treating Heart Failure

Participant-Centric, Digital, and Decentralized: What Are the Innovations We Need in How We Do Research?

Addressing the HF Physician Shortage “Crisis”

How I Manage AMI-Shock in 2024

3000 Years in the Making: Traditional Chinese Herbal Medicines for Heart Failure

The OBESITY-HF Connection: Time to Attack This Head-on

How CRISPR Will Be Used to Prevent Heart Failure

Utilization of Advanced Heart Failure Interventions Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content